Welcome to our dedicated page for CECORS news (Ticker: CEOS), a resource for investors and traders seeking the latest updates and insights on CECORS stock.
CeCors, Inc. (CEOS) is a company dedicated to empowering United States veterans through its subsidiary, VETCOMM. Led by CEO Kate Monroe, a marine veteran, VETCOMM advocates for veterans, ensuring they receive the rights and support they deserve. With a mission to bridge the gap in accessing benefits, VETCOMM offers educational resources and support platforms for veterans. The recent addition of Rafer Weigel as Chief Content Officer marks a significant milestone in VETCOMM's journey to elevate veteran services and enhance community engagement through strategic content creation.
CeCors, Inc., with its two subsidiaries, PsyKey Inc. and VETCOMM.US, operates with a focus on delivering diversified shareholder value. PsyKey specializes in the development and commercialization of therapeutic and medicinal products, while VETCOMM.US leads the way in providing veteran benefits advocacy. CeCors, through its strategic growth initiatives and successful revenue performance, aims to expand its reach, enhance services, and improve the lives of veterans.
CeCors, Inc. (OTC PINK:CEOS) announces the launch of its monthly coffee subscription services through its subsidiary, PsyKey Inc.. Targeted for corporate and individual consumers, the subscription aims to tap into a rapidly growing retail segment projected to exceed $65 billion globally by 2022. The corporate service will offer custom-designed subscriptions, while the individual program is set to launch in September 2022. These services utilize premium, ethically sourced Arabica coffee and functional mushrooms to promote convenience and quality.
CeCors, Inc. (OTC PINK:CEOS) announced on July 26, 2022, its awareness of unauthorized promotional activities affecting its stock, highlighted by a badge from OTC Markets Group. The company denies any involvement with ANC, LLC or Bullish Charts, who reportedly conducted the promotions. The promotional activities led to a decrease in stock price but had a marginal effect on trading volume. CeCors emphasizes that it has not engaged in any promotional activities nor has it entered agreements with any investor relations firms, ensuring its communications are transparent through verified channels.
CeCors, Inc. (OTC PINK: CEOS) announced the successful fulfillment of the first segment of a $50,000 order for its functional mushroom-infused coffee from Union Marketing. This initial delivery includes 900 boxes of coffee pods and marketing materials, marking a significant milestone in CeCors' distribution strategy. With a target of 1% member engagement, the company aims to acquire 7,500 customers, potentially generating nearly $250,000 in monthly revenue. CeCors emphasizes the importance of taste and customer feedback as it expands its brand awareness and distribution.
CeCors Inc. (OTC PINK: CEOS) has finalized the production of its premium functional mushroom-infused coffee line, set to launch alongside a new e-commerce website on June 20, 2022. The global functional mushroom market was valued at $7.98 billion in 2020 and is projected to reach $19.33 billion by 2030, growing at a CAGR of 9.3%. PsyKey will offer four unique coffee formulations, enriched with adaptogenic mushrooms, in single-serve pods. President Amar Bhatal highlights the quality, functionality, and taste of their products, while further distribution plans are forthcoming.
CeCors, Inc. (OTC PINK: CEOS) announced its acquisition of Nutra-Rox LLC, a company specializing in advanced carbonated delivery technology for nutraceuticals. This non-dilutive transaction allows CeCors to enhance its product offerings in the growing functional mushroom market, projected to reach $19.33 billion by 2030. Nutra-Rox’s innovative products, including the popular Breath Rox, aim to provide unique customer experiences and expand distribution channels. Nutra-Rox's management brings over 50 years of experience, promising potential synergies to boost shareholder value.
CeCors, Inc. (OTC PINK:CEOS) has announced a significant purchase order worth $50,000 for its functional mushroom-infused coffee from Union Marketing. This order marks a crucial milestone as it aligns with the company's plans for an upcoming e-commerce launch. President Amar Bhatal expressed confidence in this order being the first of many, supporting the company's goal to generate ongoing revenue and eventually remove its shell status. The product combines fair trade organic Arabica coffee beans with functional mushrooms, which have historical medicinal benefits.
CeCors, Inc. (OTC PINK:CEOS) provides an update via its subsidiary PsyKey Inc., highlighting its successful procurement of 900 kilograms of premium mushrooms amidst COVID-19 supply chain challenges. The mushrooms, verified by certificates of analysis, will be vital for developing new retail products. PsyKey has strengthened its management and is in discussions with international distribution partners. Upcoming meetings with manufacturing partners aim to solidify retail strategies and explore laboratory facilities for future growth.
CeCors, Inc. (OTC PINK:CEOS) has announced discussions to form a strategic partnership with Zealous Inc., a biotechnology firm specializing in psilocybin and psilocin production. This collaboration aims to accelerate the development of PsyKey's functional beverage and supplement products. With Zealous's expertise in bioengineering and product commercialization, the partnership is positioned to leverage upcoming clinical trials. The psychedelic drug market is projected to grow significantly by 2027, aligning with PsyKey's long-term growth strategy.
CeCors, Inc. (OTC PINK:CEOS) announced a partnership between its subsidiary PsyKey Inc. and The Professional Gardener Co. LTD to enhance the commercial mushroom production and organic farming sectors.
The collaboration aims to create innovative products that boost yields and optimize potency while retaining organic certification. Established in 1927, The Professional Gardener Co. is recognized in Canada for its horticulture solutions, focusing on plant productivity and quality assurance. PsyKey's president expressed enthusiasm for leveraging this partnership to meet the rising demand for sustainable mushroom products.
CeCors, Inc. (OTC PINK:CEOS) announces a strategic partnership with MycoVita Canada Inc. through its subsidiary, PsyKey Inc.. This alliance aims to enhance growth and market presence in the mycology sector by focusing on the research, development, and commercialization of mycology-based products and therapeutics. The partnership grants exclusive access to MycoVita’s formulations and research, potentially unlocking new distribution channels and revenue streams. Dr. Omon Isikhuemhen, an expert in mushroom science, leads this collaboration, promising advancements in product quality and efficacy.
FAQ
What is the current stock price of CECORS (CEOS)?
What is the market cap of CECORS (CEOS)?
What is the primary focus of CeCors, Inc.?
Who leads VETCOMM and what is its mission?
What recent milestone did VETCOMM achieve?
How does CeCors plan to enhance shareholder value?
What strategic initiatives is CeCors focusing on in 2024?
